Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring

INTRODUCTION: Sodium-glucose cotransporter 2 (SGLT2) inhibitors promote urinary glucose excretion. However, the differences in the effects of various SGLT2 inhibitors are unknown. We used flash glucose monitoring (FGM) to identify the differences between tofogliflozin and ipragliflozin in terms of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Yuji, Sawa, Jun, Kumeda, Yasuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644607/
https://www.ncbi.nlm.nih.gov/pubmed/33063270
http://dx.doi.org/10.1007/s13300-020-00940-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644607/
https://www.ncbi.nlm.nih.gov/pubmed/33063270
http://dx.doi.org/10.1007/s13300-020-00940-9

Ejemplares similares